Skip to main content
. 2016 Feb 12;30(5):1126–1132. doi: 10.1038/leu.2015.360

Figure 1.

Figure 1

(ad) Kaplan–Meier estimates of fibrosis-free survival and overall survival with significant differences in 232 WHO-confirmed versus 238 BCSH-defined ET patients (Figures a and b). Separate analysis of the WHO-diagnosed prePMF fraction of 77 patients included in the BCSH-classified ET cohort of 238 patients reveals a significant worsening of fibrosis-free and overall survival (Figures c and d). Abbreviation: CI, confidence interval.